Shandong Sinobioway Biomedicine Co Ltd Financial Flexibility Index

Latest as of September 2025: -0.12x

Shandong Sinobioway Biomedicine Co Ltd financial flexibility index. Shandong Sinobioway Biomedicine Co Ltd (002581) has a Financial Flexibility Index of -0.12x as of September 2025. Free cash flow of CN¥-26.32 Million (operating CF CN¥-86.58 Million minus capex CN¥60.26 Million) represents 0% of total liabilities (CN¥221.51 Million). See Shandong Sinobioway Biomedicine Co Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Financial Flexibility Index

-0.12x
Free Cash Flow / Total Liabilities

Free Cash Flow

CN¥-26.32 Million
Operating CF − Capex

Total Liabilities

CN¥221.51 Million
CNY

Capital Expenditures

CN¥60.26 Million
CNY

Financial Flexibility Index of Shandong Sinobioway Biomedicine Co Ltd (2007–2025)

Financial flexibility index of Shandong Sinobioway Biomedicine Co Ltd from 2007 to 2025. Historical Financial Flexibility Index trend for Shandong Sinobioway Biomedicine Co Ltd across 19 annual periods. Check Shandong Sinobioway Biomedicine Co Ltd (002581) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Shandong Sinobioway Biomedicine Co Ltd Financial Flexibility Index by Year (2007–2025)

Shandong Sinobioway Biomedicine Co Ltd financial flexibility index by year from 2007 to 2025. Year-by-year free cash flow to debt coverage for Shandong Sinobioway Biomedicine Co Ltd. For the full cash flow conversion analysis, see how efficiently does Shandong Sinobioway Biomedicine Co Ltd generate cash.

Year Flexibility Index Free Cash Flow (CNY) Operating CF Total Liabilities YoY Change
2025 -0.33x CN¥-74.03 Million CN¥-253.73 Million CN¥222.00 Million ▼ -2447.1%
2024 0.01x CN¥2.47 Million CN¥-6.55 Million CN¥173.61 Million ▲ +107.2%
2023 -0.20x CN¥-32.19 Million CN¥-36.51 Million CN¥163.41 Million ▼ -233.2%
2022 -0.06x CN¥-23.02 Million CN¥-54.49 Million CN¥389.46 Million ▼ -214.3%
2021 0.05x CN¥14.83 Million CN¥-46.02 Million CN¥286.76 Million ▼ -84.7%
2020 0.34x CN¥86.21 Million CN¥18.51 Million CN¥254.33 Million ▲ +310.3%
2019 0.08x CN¥84.69 Million CN¥48.41 Million CN¥1.03 Billion ▼ -82.2%
2018 0.46x CN¥682.72 Million CN¥74.46 Million CN¥1.47 Billion ▲ +39.2%
2017 0.33x CN¥359.24 Million CN¥271.11 Million CN¥1.08 Billion ▼ -75.1%
2016 1.34x CN¥214.00 Million CN¥169.32 Million CN¥160.16 Million ▲ +98.2%
2015 0.67x CN¥183.34 Million CN¥137.73 Million CN¥271.92 Million ▼ -86.6%
2014 5.01x CN¥100.70 Million CN¥80.11 Million CN¥20.08 Million ▲ +41.8%
2013 3.54x CN¥125.54 Million CN¥83.13 Million CN¥35.49 Million ▼ -30.4%
2012 5.08x CN¥125.15 Million CN¥63.04 Million CN¥24.62 Million ▼ -10.3%
2011 5.67x CN¥101.58 Million CN¥74.43 Million CN¥17.91 Million ▲ +58.9%
2010 3.57x CN¥115.39 Million CN¥85.71 Million CN¥32.34 Million ▲ +80.4%
2009 1.98x CN¥69.69 Million CN¥54.06 Million CN¥35.24 Million ▼ -30.5%
2008 2.85x CN¥78.00 Million CN¥46.89 Million CN¥27.41 Million ▲ +6.6%
2007 2.67x CN¥30.98 Million CN¥25.07 Million CN¥11.60 Million —
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities